High treatment success in children treated for multidrug-resistant tuberculosis: An observational cohort study

Thorax

Volumn 69, Issue 5, 2014, Pages 471-477

  Seddon, James A ^a,b,c   Hesseling, Anneke C ^a   Godfrey Faussett, Peter ^b   Schaaf, H Simon ^a,d  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ARTICLE; DOSE RESPONSE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFANT; ISOLATION AND PURIFICATION; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PAEDIATRIC LUNG DISAESE; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS;

PAEDIATRIC LUNG DISAESE; RESPIRATORY INFECTION; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; MALE; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDIES; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84898871000     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-203900     Document Type: Article

References (31)

1. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. 4th edn. Geneva, Switzerland: WHO, 2009. WHO/HTM/TB/2009.422.
2. World Health Organization. Tuberculosis prevalence surveys: a handbook. Geneva, Switzerland: WHO, 2010. WHO/HTM/TB/2010.17.
3. World Health Organization. Global tuberculosis control. Geneva, Switzerland: WHO, 2011. WHO/HTM/TB/201116 http://wwwwhoint/tb/publications/ global-report/2011/gtbr11-fullpdf (accessed Jul. 2013).
4. Marais BJ, Hesseling AC, Gie RP, et al. The burden of childhood tuberculosis and the accuracy of community-based surveillance data. Int J Tuberc Lung Dis 2006;10:259-63.
5. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis-emergency update. Geneva, Switzerland: WHO, 2008. WHO/HTM/TB/2008402. http://whqlibdocwhoint/publications/2008/9789241547581- engpdf (accessed Jul. 2013).
6. Ettehad D, Schaaf HS, Seddon JA, et al. Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012;12:449-56.
7. Zar HJ, Hanslo D, Apolles P, et al. Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet 2005;365:130-4. (Pubitemid 40091802)
8. Marais BJ, Hesseling AC, Gie RP, et al. The bacteriologic yield in children with intrathoracic tuberculosis. Clin Infect Dis 2006;42:e69-71.
9. World Health Organization. Guidance for National Tuberculosis Programmes on the management of tuberculosis in children. Geneva, Switzerland: WHO, 2006. WHO/HTM/TB/2006371, WHO/FCH/CAH/20067. http://whqlibdocwhoint/hq/2006/WHO-HTM- TB-2006371-engpdf (accessed Jul. 2013).
10. World Health Organization. Guidelines for the programmatic management of drugresistant tuberculosis. Geneva, Switzerland: WHO, 2011. update. WHO/HTM/TB/2011.6.
11. Marais BJ, Gie RP, Schaaf HS, et al. The spectrum of disease in children treated for tuberculosis in a highly endemic area. Int J Tuberc Lung Dis 2006;10:732-8. (Pubitemid 44031385)
12. Marais BJ, Gie RP, Hesseling AH, et al. Adult-type pulmonary tuberculosis in children 10-14 years of age. Pediatr Infect Dis J 2005;24:743-4. (Pubitemid 41140966)
13. Marais BJ, Gie RP, Hesseling AC, et al. Radiographic signs and symptoms in children treated for tuberculosis: possible implications for symptom-based screening in resource-limited settings. Pediatr Infect Dis J 2006;25:237-40. (Pubitemid 43379064)
14. Seddon JA, Furin JJ, Gale M, et al. Caring for children with drug-resistant tuberculosis: practice-based recommendations. Am J Respir Crit Care Med 2012;186:953-64.
15. Wiseman CA, Gie RP, Starke JR, et al. A proposed comprehensive classification of tuberculosis disease severity in children. Pediatr Infect Dis J 2012;31:347-52.
16. South African Health Review 2010. Health and related indicators. http://www.hst.org.za/sites/default/files/sahr10-21.pdf (accessed Jul. 2013).
17. Seddon JA, Hesseling AC, Marais BJ, et al. The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa. Int J Tuberc Lung Dis 2012;16:928-33.
18. Statistics South Africa. Census 2011. http://www.statssa.gov. za/Census2011/Products/Census-2011-Census-in-brief.pdf (accessed Jul. 2013).
19. Hazbon MH, Brimacombe M, Bobadilla Del Valle M, et al. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 2006;50:2640-9. (Pubitemid 44198682)
20. Warren RM, Gey Van Pittius NC, Barnard M, et al. Differentiation of Mycobacterium tuberculosis complex by PCR amplification of genomic regions of difference. Int J Tuberc Lung Dis 2006;10:818-22. (Pubitemid 44031399)
21. Barnard M, Albert H, Coetzee G, et al. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008;177:787-92. (Pubitemid 351490566)
22. Schaaf HS, Victor TC, Engelke E, et al. Minimal inhibitory concentration of isoniazid in isoniazid-resistant Mycobacterium tuberculosis isolates from children. Eur J Clin Microbiol Infect Dis 2007;26:203-5.
23. World Health Organisation. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva, Switzerland: WHO, 2007. ISBN: 978 92 4 159562 9.
24. Seddon JA, Perez-Velez CM, Schaaf HS, et al. Consensus statement on research definitions for drug-resistant tuberculosis in children. J Pediatric Infect Dis Soc 2013;2:100-109.
25. Marais BJ, Gie RP, Schaaf HS, et al. A proposed radiological classification of childhood intra-thoracic tuberculosis. Pediatr Radiol 2004;34:886-94. (Pubitemid 39462398)
26. Division of Microbiology and Infectious Diseases. Pediatric Toxicity Tables. November 2007 DRAFT. http://www.niaid.nih.gov/LabsAndResources/ resources/DMIDClinRsrch/Documents/dmidpedtox.pdf (accessed Jul. 2013).
27. American Speech-Language-Hearing Association. Audiologic management of inidividuals receiving cochleotoxic drug therapy (guideline). 1994. http://www.asha.org/docs/pdf/GL1994-00003.pdf (accessed Aug. 2012).
28. Seddon JA, Hesseling AC, Willemse M, et al. Culture-confirmed multidrug-resistant tuberculosis in children: clinical features, treatment, and outcome. Clin Infect Dis 2012;54:157-66.
29. Orenstein EW, Basu S, Shah NS, et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis 2009;9:153-61.
30. Johnston JC, Shahidi NC, Sadatsafavi M, et al. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS ONE 2009;4:e6914.
31. Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004;8:392-402. (Pubitemid 38624845)